A world leader in medical device coatings, SurModics technology has been used successfully on more than 200 commercial devices in the areas of cardiology, neurology, diabetes, gastrointestinal, obesity, oncology, and urology.
SurModics’ hydrophilic, lubricious coatings reduce the coefficient of friction on a vast array of materials even under extreme clinical conditions. The company’s extensive knowledge of these coatings has led to a recent breakthrough in the industry—the new Serene™ low friction, low particulate coating platform.
Other SurModics coating technologies include hemocompatible coatings that reduce platelet adhesion and thrombus formation; and, biocompatible polymer drug delivery coatings that meet therapeutic dosing and duration requirements
SurModics patented coating technologies have several advantages:
- Flexibility to coat a wide variety of materials and devices
- Efficient, high-throughput manufacturing with minimal floor space requirements
- The ability to test and package devices just minutes after coating
- No harsh chemicals or hazardous byproducts
SurModics provides critical, comprehensive services throughout the product development cycle, from feasibility to commercialization.
- Compliant to ISO 9001:2008 and ISO 13485:2003
- World-class analytical and surface characterization capabilites
- Contract coating services and manufacturing support for devices in pre-clinical and clinical stages
- Technology transfer service for customers to integrate the coating process into their existing manufacturing systems
- Ongoing technical, regulatory and manufacturing support
For over 30 years, SurModics has worked with several of the world`s leading medical device companies and emerging start-ups. SurModics` coating technology platforms provide simplicity, versatility, and excellent performance, with high-quality coatings and consistent outcomes.
